25 results on '"Bulgheroni, Elisabetta"'
Search Results
2. Identification of Lymphangioleiomyomatosis-associated Serum MicroRNAs
3. Extracellular MicroRNA Signature of Human Helper T Cell Subsets in Health and Autoimmunity
4. Pharmacologic Rescue of Impaired Cognitive Flexibility, Social Deficits, Increased Aggression, and Seizure Susceptibility in Oxytocin Receptor Null Mice: A Neurobehavioral Model of Autism
5. Dual modulation of inward rectifier potassium currents in olfactory neuronal cells by promiscuous G protein coupling of the oxytocin receptor
6. Efficacy and tolerability of multiple drug therapy in HIV-infected children
7. Unusual codon 69 insertions: influence on human immunodeficiency virus type 1 reverse transcriptase drug susceptibility
8. Analysis of protease inhibitor combinations in vitro: activity of lopinavir, amprenavir and tipranavir against HIV type 1 wild-type and drug-resistant isolates
9. Accumulation of drug-related mutations in HIV-1 genome and virus replicative capacity in multi-drug failure subjects
10. Identification of serum microRNAs in patients with Lymphangioleiomyomatosis
11. Sirolimus Therapy for Patients With Lymphangioleiomyomatosis Leads to Loss of Chylous Ascites and Circulating LAM Cells
12. Intracellular Modulation, Extracellular Disposal and Serum Increase of MiR-150 Mark Lymphocyte Activation
13. Selective and Potent Agonists and Antagonists for Investigating the Role of Mouse Oxytocin Receptors
14. New Macrocyclic Amines Showing Activity as HIV Entry Inhibitors Against Wild Type and Multi-Drug Resistant Viruses
15. Absence of New Thymidine-Associated Mutations and Evidence of an Immune Virologic Response Over a 12-Month Period in a Cohort of Antiretroviral-Experienced HIV-1-Infected Subjects Treated With Tenofovir Combination Therapy
16. Analysis of theenvV3 Sequences Obtained from Patients with HIV Type 1 Infection Treated with the Immune Modulant Agent Tucaresol
17. Entry and fusion inhibitors of HIV
18. Virological Response in Multidrug-Experienced HIV-1-Infected Subjects Failing Highly Active Combination Regimens after Shifting from Lamivudine to Didanosine
19. Combination of CCR5 and CXCR4 Inhibitors in Therapy of Human Immunodeficiency Virus Type 1 Infection: In Vitro Studies of Mixed Virus Infections
20. In Vitro Inhibition of HIV-1 by Met-Sdf-1β Alone or in Combination with Antiretroviral Drugs
21. Loss of Lamivudine Resistance in a Zidovudine and Lamivudine Dual-Resistant HIV-1 Isolate after Discontinuation of In Vitro Lamivudine Drug Pressure
22. Absence of New Thymidine-Associated Mutations and Evidence of an Immune Virologic Response Over a 12-Month Period in a Cohort of Antiretroviral-Experienced HIV-1-Infected Subjects Treated With Tenofovir Combination Therapy.
23. Analysis of the env V3 Sequences Obtained from Patients with HIV Type 1 Infection Treated with the Immune Modulant Agent Tucaresol
24. In Vitro Inhibition of HIV-1 by Met-Sdf-1ß Alone or in Combination with Antiretroviral Drugs
25. Loss of Lamivudine Resistance in a Zidovudine and Lamivudine Dual-Resistant HIV-1 Isolate after Discontinuation of In VitroLamivudine Drug Pressure
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.